Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription Articles published in Acta Radiol Retrieve available abstracts of 11 articles: HTML format

Single Articles

December 2023
1. KRAUSS W, Frey J, Heydorn Lagerlof J, Liden M, et al
   Radiomics from multisite MRI and clinical data to predict clinically significant prostate cancer.
   Acta Radiol. 2023 Dec 20:2841851231216555. doi: 10.1177/02841851231216555.
   PubMed     Abstract available
   
   
   August 2023
2. YANG YY, Liu ZM, Peng RC
   Diagnostic performance of 18F-labeled PSMA PET/CT in patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
   Acta Radiol. 2023 Aug 6:2841851231184210. doi: 10.1177/02841851231184210.
   PubMed     Abstract available
   
   
   July 2023
3. STEVENS W, Parchment-Smith C, Adiotomre E, Hulson O, et al
   Is Likert better than PI-RADS at predicting prostate cancer on MRI and can a mathematical algorithm achieve similar results?
   Acta Radiol. 2023 Jul 12:2841851231187135. doi: 10.1177/02841851231187135.
   PubMed     Abstract available
   
   
   April 2023
4. KIZILGOZ V, Kantarci M, Tonkaz G, Levent A, et al
   Incidental findings on prostate MRI: a close look at the field of view in this anatomical region.
   Acta Radiol. 2023;64:1676-1693.
   PubMed     Abstract available
   
   
   July 2022
5. STEVENS WM, Parchment-Smith C, Melling PP, Smith JT, et al
   Making an art into a science: a mathematical "Likert tool" can change PI-RADS (v2) scores into Likert scores when reporting multiparametric MRI for prostate cancer.
   Acta Radiol. 2022 Jul 11:2841851221112194. doi: 10.1177/02841851221112194.
   PubMed     Abstract available
   
   
   June 2022
6. MAKELA P, Wright C, Anttinen M, Bostrom PJ, et al
   Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers.
   Acta Radiol. 2022 Jun 24:2841851221108292. doi: 10.1177/02841851221108292.
   PubMed     Abstract available
   
   
   
7. LEBOVICI A, Csutak C, Popa P, Crisan N, et al
   Magnetic resonance imaging characteristics of chronic prostatitis in patients under the age of 50: is it more than the eye can see?
   Acta Radiol. 2022;63:839-846.
   PubMed     Abstract available
   
   
   April 2022
8. CHUNG JH, Park BK
   Transrectal ultrasound features and biopsy outcomes of transition PI-RADS 5.
   Acta Radiol. 2022;63:559-565.
   PubMed     Abstract available
   
   
   February 2022
9. PARK SB
   Quantitative relaxation maps from synthetic MRI for prostate cancer.
   Acta Radiol. 2022 Feb 24:2841851221077405. doi: 10.1177/02841851221077405.
   PubMed    
   
   
   September 2021
10. THOMSEN HS
    International Scientific Prize.
    Acta Radiol. 2021;62:1131.
    PubMed    
    
    
    June 2021
11. LINHARES MOREIRA AS, De Visschere P, Van Praet C, Villeirs G, et al
    How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.
    Acta Radiol. 2021;62:839-847.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.